Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Adjuvant in Gastric/EGJ Cancer
NCT02564367Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- Oct 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in gastric adenocarcinoma, esophagogastric junction adenocarcinoma (GEJA), sponsored by AIO-Studien. Started Oct 2015; status: completed.
02
Drugs
tegafur
03
Conditions
gastric adenocarcinomaesophagogastric junction adenocarcinoma (GEJA)
Beyond the preview
Go deeper on NCT02564367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564367.